Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enfusion Inc Cl A (NY: ENFN ) 9.300 -0.030 (-0.32%) Official Closing Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Enfusion Inc Cl A < Previous 1 2 3 Next > ENFN Stock Earnings: Enfusion Misses EPS, Misses Revenue for Q2 2024 August 06, 2024 ENFN stock results show that Enfusion missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace ENFN Stock Earnings: Enfusion Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 ENFN stock results show that Enfusion beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024 April 04, 2024 Equities have only become more expensive, but investors should still lookout for the most undervalued under-$10 stocks to buy in April. Via InvestorPlace Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024 March 15, 2024 U.S. equities market is rallying, but there are still interesting investments to make, especially for these strong-buy stocks under $10. Via InvestorPlace 12 Information Technology Stocks Moving In Thursday's Pre-Market Session March 14, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts March 13, 2024 Via Benzinga Earnings Outlook For Enfusion March 11, 2024 Via Benzinga JP Morgan Downgrades Enfusion: Here's What You Need To Know January 30, 2024 Via Benzinga Earnings Preview: Enfusion August 07, 2023 Via Benzinga Earnings Scheduled For March 12, 2024 March 12, 2024 Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. Via Benzinga Wall Street's Top 10 Stock Calls This Week - Saturday, March 2 March 02, 2024 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1. Via Talk Markets Why Enfusion (ENFN) Stock Is Exploding Higher June 26, 2023 Enfusion Inc (NYSE: ENFN) shares are trading higher by 20% to $11.06 Monday afternoon following a report suggesting the company is attracting takeover interest. What Else? Via Benzinga What 4 Analyst Ratings Have To Say About Enfusion April 03, 2023 Via Benzinga Analyst Ratings for Enfusion March 15, 2023 Via Benzinga Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock February 28, 2024 Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific... Via Benzinga This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts January 02, 2024 U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its... Via Benzinga Topics Stocks Exposures US Equities Hidden Gems: 3 Small-Cap Tech Stocks With Huge Potential December 06, 2023 These top small-cap tech stocks are the ones to buy in for long-term returns as profits are evident from innovations. Via InvestorPlace The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023 September 19, 2023 Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well. Via InvestorPlace 12 Information Technology Stocks Moving In Monday's Intraday Session June 26, 2023 Via Benzinga Why Enfusion Stock Surged Today March 07, 2023 The company is growing profitably -- unusual for a small software company. Via The Motley Fool Enfusion's Earnings: A Preview March 06, 2023 Via Benzinga Looking Into Enfusion's Return On Capital Employed December 21, 2022 Via Benzinga McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday May 09, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 April 03, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023 March 15, 2023 Via Benzinga Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday March 07, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Nasdaq Down 50 Points; Crude Oil Rises Over 1% November 29, 2022 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 50 points on Tuesday. Via Benzinga Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 07, 2023 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... Via Benzinga Peering Into Enfusion's Recent Short Interest November 29, 2022 Enfusion's (NYSE:ENFN) short percent of float has fallen 6.89% since its last report. The company recently reported that it has 2.13 million shares sold short, which is 7.43% of all regular shares that... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 January 04, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
